Determining the worldwide prevalence of obesity - Authors' reply.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Late isocaloric eating increases hunger, decreases energy expenditure, and modifies metabolic pathways in adults with overweight and obesity.Cell metabolism · 2022
   Trial
2. General and central obesity prevalence in young adult: a study based on the Rafsanjan youth cohort study.Scientific reports · 2023
   Article
3. Personality Features in Obesity.Frontiers in psychology · 2020
   Article
4. Obesity is not associated with progression to end stage renal disease in patients with biopsy-proven glomerular diseases.BMC nephrology · 2019
   Article

Corrections and comments

• Comment on
  Determining the worldwide prevalence of obesity.2018

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as